FDA approves first use of CRISPR gene editing to treat sickle cell disease
The Food and Drug Administration (FDA) on Friday approved a new therapy for treating sickle cell disease, with this move also marking the first instance of CRISPR gene editing receiving approval from federal regulators. The FDA approved two new treatments for sickle cell disease (SCD) on Friday, Casgevy and Lyfgenia. Casgevy, also known as exa-cel, […]